Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs HealthRX
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict86/ 100
Grade B · #8HealthRX
A rare oral GLP tablet alongside both injectables, with the full plan table published on-site — though the headline $99 and $179 rates are 12-month prepay floors, not what a month-to-month patient pays.
Visit HealthRXThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 86/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. HealthRX still earns its place — patients who want a physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results85
92
Real-world results85
97Price honesty85
97
Price honesty85
96Prescriber access89
96
Prescriber access89
88Formulary choice90
88
Formulary choice90
95Cancellation fairness84
95
Cancellation fairness84
93Member support84
93
Member support84
Price, coverage & features
| Metric | CoreAge Rx | HealthRX |
|---|---|---|
| Verdict Score | 94/100 | 86/100 |
| Grade | A | B |
| Semaglutide | $99/mo | $99/mo (annual) |
| Tirzepatide | $149/mo | $179/mo (annual) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
HealthRX
What we like
- Physician-supervised intake with licensed prescribers
- Carries both molecules plus a rare oral GLP tablet — real route choice
- Full plan table published on-site with a current-as-of date: semaglutide $190/mo month-to-month down to $99/mo on the 12-month plan, tirzepatide $239/mo down to $179/mo — no insurance required
- Cancel online in one click, unshipped doses refunded, 30-day money-back guarantee and a full refund if a provider doesn't approve you
The caveats
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- The advertised $99 and $179 rates require a 12-month prepay — $1,188 and $2,148 up front; month-to-month runs $190 and $239
- Brand Ozempic is pass-through at ~$1,299/mo — the path exists but is priced out of reach for most
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients who want a physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Visit HealthRX Read the full HealthRX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for HealthRX does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.